10-71707053-C-T
Variant summary
Our verdict is Likely benign. The variant received -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_022124.6(CDH23):c.3106+4C>T variant causes a splice region, intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000138 in 1,445,868 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 1/1 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_022124.6 splice_region, intron
Scores
Clinical Significance
Conservation
Publications
- autosomal recessive nonsyndromic hearing loss 12Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), G2P, PanelApp Australia
- nonsyndromic genetic hearing lossInheritance: AR Classification: DEFINITIVE Submitted by: ClinGen
- Usher syndrome type 1Inheritance: AR Classification: DEFINITIVE, SUPPORTIVE Submitted by: ClinGen, Orphanet
- Usher syndrome type 1DInheritance: AR Classification: DEFINITIVE, STRONG Submitted by: G2P, Labcorp Genetics (formerly Invitae), PanelApp Australia
- hearing loss, autosomal recessiveInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Our verdict: Likely_benign. The variant received -2 ACMG points.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| CDH23 | NM_022124.6 | c.3106+4C>T | splice_region_variant, intron_variant | Intron 26 of 69 | ENST00000224721.12 | NP_071407.4 | ||
| CDH23 | NM_001171931.2 | c.3110C>T | p.Ala1037Val | missense_variant | Exon 26 of 26 | NP_001165402.1 | ||
| CDH23 | NM_001171930.2 | c.3106+4C>T | splice_region_variant, intron_variant | Intron 26 of 31 | NP_001165401.1 |
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| CDH23 | ENST00000224721.12 | c.3106+4C>T | splice_region_variant, intron_variant | Intron 26 of 69 | 5 | NM_022124.6 | ENSP00000224721.9 |
Frequencies
GnomAD3 genomes Cov.: 33
GnomAD4 exome AF: 0.00000138 AC: 2AN: 1445868Hom.: 0 Cov.: 31 AF XY: 0.00000139 AC XY: 1AN XY: 717732 show subpopulations
Age Distribution
GnomAD4 genome Cov.: 33
ClinVar
Submissions by phenotype
not specified Uncertain:1
Variant classified as Uncertain Significance - Favor Benign. The Ala1037Val vari ant in CDH23 (NM_01171391.1) has not been previously reported in individuals wit h hearing loss and was absent from large population studies. The alanine (Ala) a t position 1037 is not conserved in mammals or evolutionary distant species, rai sing the possibility that a change at this position may be tolerated. Additional computational prediction tools suggest the Ala1037Val variant may not impact th e protein, though this information is not predictive enough to rule out pathogen icity. Note that in an alternate transcript of CDH23, the variant occurs at the +4 splice site position (c.3106+4C>T in NM_022124.5). However, this variant does not affect the invariant +1/+2 positions of the splice site consensus sequence and computational tools do not predict an impact to splicing. In summary, while the clinical significance of the Ala1037Val variant is uncertain, these data sug gest that is more likely to be benign. -
Usher syndrome type 1 Uncertain:1
- -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at